Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Purpura, Thrombocytopenic, Idiopathic 1Neoplasms 1Lymphedema 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Inosine Triphosphate × Clear all
NCT06444477 2026-01-26

MATAC

University Hospital, Bordeaux

Completed
33 enrolled

Neoplasms, Purpura, Thrombocytopenic, Idiopathic

NCT02528539 2022-03-02

Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)

Huntington Memorial Hospital

Phase NA Completed
10 enrolled

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡